Columbus McKinnon Corp. (NY) (CMCO) Hits New 52-week Low During January 12 Session

Equities Staff |

Columbus McKinnon Corp. (NY) (CMCO) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $17.03, Columbus McKinnon Corp. (NY) dropped to $16.30 for a new 52-week low. By the closing bell, the company's stock was at $16.53 a share for a loss of 1.72%.

Falling to a new 52-week low is never fun for company's shareholder, but, depending on who you ask, it can be either a buy or a sell signal. Someone bearish on the stock might see it reaching its lowest price in a year as a sign of growing downward momentum and make sure they sell their shares. Bulls, though, are more likely to see a new 52-week low as the stock hitting its low point and anticipate a bounce in the share price.

However one plays it, it's often a critical moment for any stock and should be noted by investors.

Columbus McKinnon Corp. (NY) saw 41,594 shares of its stock trade hands, that's out of 20.1 million shares outstand. The stock has an average daily volume of 74,216 shares. After hitting a new 52-week low, Columbus McKinnon Corp. (NY) enters the new trading day with a market cap of 332.28 million, a 50-day SMA of $19.09 and a 200-day SMA of $21.56

Columbus McKinnon Corp. (NY) now has a P/E ratio of 21.

For a complete fundamental analysis analysis of Columbus McKinnon Corp. (NY), check out’s Stock Valuation Analysis report for CMCO. To see the latest independent stock recommendations from’s analysts, visit our Research section.

Columbus McKinnon Corp is a designer, manufacturer and marketer of hoists, rigging tools, cranes, actuators, and other material handling products serving commercial and industrial end-user markets.

Columbus McKinnon Corp. (NY) has 2,747 employees, is led by CEO Timothy T. Tevens, and makes its home in Amherst, NY.

Columbus McKinnon Corp. (NY) is also a component of the Russell 2000 Index, which is generally viewed as the most reliable indicator of the health of the broader small-cap market. Using a rules-based methodology, it creates a simple, unbiased view of how America's stable of smaller publicly traded companies are performing in the stock markets.

The index consists of the 2,000 smallest companies of the 3,000 largest publicly-traded companies in the country as judged by market cap. It's constructed by Russell Investments, which also builds and maintains the Russell 3000 (an index consisting of all 3,000 biggest companies by market cap) and the large-cap Russell 1000 (which has the 1,000 largest companies from the Russell 3000).

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

Quants Inc

Quants, Inc, a California Corporation, develops, markets and operates financial technology platforms and alternative investment products offering sophisticated risk management since 2010. The Company has primarily sharpened its focus with…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…